Zdrowie i gospodarka · 26/12/2012
FDA Announces Draft Environmental Assessment and Preliminary Finding of No Significant Impact for Genetically Engineered Atlantic Salmon
The FDA is seeking public comment on its draft environmental assessment and preliminary finding of no significant impact for a genetically engineered Atlantic salmon, submitted by AquaBounty Technologies, Inc. in support of a new animal drug application.
Source: Federal Register — Food and Drug AdministrationOpen original release →